期刊
WORLD JOURNAL OF GASTROENTEROLOGY
卷 20, 期 40, 页码 14717-14725出版社
BAISHIDENG PUBLISHING GROUP INC
DOI: 10.3748/wjg.v20.i40.14717
关键词
Pancreatic cancer; Diagnosis; Treatment; Signaling pathways; Nanomedicine; Biomarkers
资金
- National Institutes of Health (NIH) R01 [5R01CA167535-02]
With the incidence reports of pancreatic cancer increasing every year, research over the last several decades has been focused on the means to achieve early diagnosis in patients that are at a high risk of developing the malignancy. This review covers current strategies for managing pancreatic cancer and further discusses efforts in understanding the role of early onset symptoms leading to tumor progression. Recent investigations in this discussion include type 3c diabetes, selected biomarkers and pathways related to pancreatic intraepithelial neoplasia lesions, drug resistance, and advances in nanomedicine which may provide significant solutions for improving early detection and treatments in future medicine. (C) 2014 Baishideng Publishing Group Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据